Etrade Cap Management Ltd invested in 4,528 shares or 0.02% of the stock. BioMarin Pharmaceutical (NASDAQ:BMRN) traded up $4.49 on Friday, hitting $93.02. Investors sentiment increased to 1.21 in Q2 2017. Its down 0.13, from 1.26 in 2017Q1. It is positive, as 68 investors sold SBUX shares while 409 reduced holdings.